Top 10 Best-Performing Pharmaceutical Stocks YTD: SOMX, AEN, GNVC, RNN, IPCI, IDEV, MAPP, QCOR, HSKA, AMLN (Mar 29, 2010)

Below are the top 10 best-performing Pharmaceutical stocks year-to-date.

Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) is the 1st best-performing stock year-to-date in this segment of the market. It has risen 741.67% since the beginning of this year. Its price percentage change is 2356.09% for the last 52 weeks. Adeona Pharmaceuticals, Inc. (AMEX:AEN) is the 2nd best-performing stock year-to-date in this segment of the market. It has risen 178.57% since the beginning of this year. Its price percentage change is 818.19% for the last 52 weeks. GenVec, Inc. (NASDAQ:GNVC) is the 3rd best-performing stock year-to-date in this segment of the market. It has risen 141.67% since the beginning of this year. Its price percentage change is 574.42% for the last 52 weeks. Rexahn Pharmaceuticals, Inc. (AMEX:RNN) is the 4th best-performing stock year-to-date in this segment of the market. It has risen 133.82% since the beginning of this year. Its price percentage change is 103.85% for the last 52 weeks. IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) is the 5th best-performing stock year-to-date in this segment of the market. It has risen 81.41% since the beginning of this year. Its price percentage change is 16.75% for the last 52 weeks.

Indevus Pharmaceuticals (NASDAQ:IDEV) is the 6th best-performing stock year-to-date in this segment of the market. It has risen 78.34% since the beginning of this year. Its price percentage change is 15.46% for the last 52 weeks. MAP Pharmaceuticals Inc. (NASDAQ:MAPP) is the 7th best-performing stock year-to-date in this segment of the market. It has risen 70.51% since the beginning of this year. Its price percentage change is 652.31% for the last 52 weeks. Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) is the 8th best-performing stock year-to-date in this segment of the market. It has risen 65.26% since the beginning of this year. Its price percentage change is 64.23% for the last 52 weeks. Heska Corporation (NASDAQ:HSKA) is the 9th best-performing stock year-to-date in this segment of the market. It has risen 61.14% since the beginning of this year. Its price percentage change is 240.00% for the last 52 weeks. Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) is the 10th best-performing stock year-to-date in this segment of the market. It has risen 59.76% since the beginning of this year. Its price percentage change is 68.30% for the last 52 weeks.